Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage

NCT06899464 is registered in ClinicalTrials.gov with Cardinal Stefan Wyszynski University as lead sponsor.

NCT NCT06899464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06899464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage
Lead sponsor
Cardinal Stefan Wyszynski University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 1, 2025
Completion date
April 1, 2027
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhagic stroke, hemorrhagic stroke, intracerebral, intracerebral hemorrhage, stroke